SNCA and Parkinson disease: We confirmed that DKI is a sensitive translational marker of alpha-synuclein and alpha-synuclein-induced brain pathology early in the course of the disease (in preclinical stages)79 as well as a dynamic marker for monitoring the spread of brain pathology in all of these animal models and in humans with PD of various cognitive subtypes77,79,80.